Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Bevacizumab 11durvalumab 9atezolizumab 9Specimen Handling 9tremelimumab 8lenvatinib 7Nivolumab 6Magnetic Resonance Spectroscopy 5X-Rays 4Sorafenib 3Oxaliplatin 3Ipilimumab 3Fluorouracil 3tislelizumab 2sapanisertib 2relatlimab 2cabozantinib 2Surgical Procedures, Operative 2Radiation 2Leucovorin 2Immunotherapy 2Immunoglobulin G 2Doxorubicin 2Disulfides 2Carboplatin 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1sofosbuvir-velpatasvir drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Hepatectomy × 30 days × Clear all
NCT07581769 2026-05-14

Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging

First Affiliated Hospital, Sun Yat-Sen University

Active not recruiting
500 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡